Capital Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,053
Closed -$203K 760
2025
Q4
$203K Buy
+3,053
New +$197K ﹤0.01% 698
2025
Q3
Sell
-2,839
Closed -$248K 734
2025
Q2
$248K Buy
+2,839
New +$223K ﹤0.01% 615
2025
Q1
Sell
-2,648
Closed -$206K 685
2024
Q4
$206K Buy
+2,648
New +$196K ﹤0.01% 618

Other funds holding DXCM

Capital Investment Advisors's DXCM Position: Q1 2026 in Review

Capital Investment Advisors sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,053 shares — an estimated $203K sold.

Capital Investment Advisors first reported a position in DXCM in Q4 2024 and held it in 3 quarters. The position peaked at $248K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Capital Investment Advisors reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Capital Investment Advisors sold 3,053 DexCom shares in Q1 2026, an estimated $203K.
  • Capital Investment Advisors first reported a position in DexCom in Q4 2024 and held it in 3 quarters.
  • Capital Investment Advisors's DexCom position peaked at $248K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.